KeyBanc analysts initiated coverage of PAREXEL International Corp. (PRXL) with a hold rating on Thursday.
Price target information was unavailable.
Parexel International Corp is a biopharmaceutical company, providing expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the pharmaceutical and biotechnology. PRXL closed the shortened session up 0.1% at $53.75. The stock trades near the top end of the 52-week range of $37.53 to $57.25.
Price: 53.72 Price Change: +0.11 Percent Change: +0.21